TRENDING TOPICS AND NEWS IN HCT AND CELLULAR THERAPY

Early research suggests leucine rich repeat containing 15 (LRRC15), which is highly present in osteosarcoma tumors but limited in normal tissues, has potential as a target antigen for chimeric...

Experiments with mice and observations in humans justify clinical trial evaluation of pentagastrin as an intervention against acute graft-versus-host disease (aGVHD), researchers report.

Investigators believe cytokine-induced killer (CIK) cell infusion, administered after autologous stem cell transplantation (ASCT), may represent a viable postremission regimen for patients with...

Research findings showcase betibeglogene autotemcel (beti-cel) as a viable and potentially curative intervention for transfusion-dependent ß-thalassemia (TDT). In this setting, hematopoietic stem...

Chimeric antigen receptor (CAR) T-cell therapy has not achieved the same level of success with solid tumors as it has with hematological cancers, but results of a preclinical experiment suggest...

Designing chimeric antigen receptor (CAR) T regulatory cells (Tregs) to detect glutamic acid decarboxylase, 65 kD isoform (GAD65) has the potential to reverse type 1 diabetes (T1D) in adults,...